Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05091346
Title A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eisai Inc.


hepatocellular carcinoma

colorectal cancer


E7386 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA | ESP

No variant requirements are available.